|
20 Apr 2025 |
Fortis Healthcare
|
Consensus Share Price Target
|
664.55 |
736.67 |
- |
10.85 |
buy
|
|
|
|
|
08 Mar 2025
|
Fortis Healthcare
|
Axis Direct
|
664.55
|
693.00
|
629.50
(5.57%)
|
Target met |
Buy
|
|
|
We recommend a BUY rating on the stock with a target price of Rs 693/share, implying an upside of 10% from the CMP
|
|
11 Feb 2025
|
Fortis Healthcare
|
Prabhudas Lilladhar
|
664.55
|
760.00
|
615.45
(7.98%)
|
14.36 |
Buy
|
|
|
|
|
11 Feb 2025
|
Fortis Healthcare
|
Axis Direct
|
664.55
|
860.00
|
615.45
(7.98%)
|
29.41 |
Buy
|
|
|
We maintain a BUY rating on Fortis Healthcare with a target price of Rs 860/share.
|
|
11 Dec 2024
|
Fortis Healthcare
|
Axis Direct
|
664.55
|
860.00
|
713.70
(-6.89%)
|
29.41 |
Buy
|
|
|
We recommend Fortis Healthcare Ltd. with a BUY rating and a target price of Rs 860/share, indicating a 20% upside from the CMP.
|
|
09 Feb 2024
|
Fortis Healthcare
|
Prabhudas Lilladhar
|
664.55
|
480.00
|
434.95
(52.79%)
|
Target met |
Buy
|
|
|
|
|
21 Nov 2023
|
Fortis Healthcare
|
Geojit BNP Paribas
|
664.55
|
390.00
|
372.40
(78.45%)
|
Target met |
Hold
|
|
|
|
|
12 Nov 2023
|
Fortis Healthcare
|
Prabhudas Lilladhar
|
664.55
|
400.00
|
358.40
(85.42%)
|
Target met |
Buy
|
|
|
|
|
17 Aug 2023
|
Fortis Healthcare
|
Geojit BNP Paribas
|
664.55
|
340.00
|
318.05
(108.95%)
|
Target met |
Hold
|
|
|
|
|
08 Aug 2023
|
Fortis Healthcare
|
ICICI Securities Limited
|
664.55
|
390.00
|
323.90
(105.17%)
|
Target met |
Buy
|
|
|
Fortis’s Q1 hospital EBITDA performance was disappointing (margins at 15.2% vs our estimate of 16.5% and Q4FY23’s 16.4%). New bed addition took a toll on margins of Mulund hospital (less than 10% vs 20-25% earlier) while seasonality at a few facilities led to a drop in overall occupancy to 64% vs 65% in Q1FY23 and 67% in Q4FY23.
|
|
22 Jun 2023
|
Fortis Healthcare
|
Prabhudas Lilladhar
|
664.55
|
365.00
|
309.20
(114.93%)
|
Target met |
Buy
|
|
|
|
|
30 May 2023
|
Fortis Healthcare
|
Geojit BNP Paribas
|
664.55
|
316.00
|
281.05
(136.45%)
|
Target met |
Accumulate
|
|
|
|
|
25 May 2023
|
Fortis Healthcare
|
ICICI Securities Limited
|
664.55
|
360.00
|
287.60
(131.07%)
|
Target met |
Buy
|
|
|
Fortis Healthcare’s (FHL) hospital business grew strong 6.6% QoQ driven by ARPOB improvement, specialty and payor mix. Most of its key hospitals reported strong sequential growth.
|
|
24 May 2023
|
Fortis Healthcare
|
Prabhudas Lilladhar
|
664.55
|
330.00
|
287.60
(131.07%)
|
Target met |
Buy
|
|
|
|
|
13 Feb 2023
|
Fortis Healthcare
|
Prabhudas Lilladhar
|
664.55
|
360.00
|
272.25
(144.10%)
|
Target met |
Buy
|
|
|
|
|
15 Nov 2022
|
Fortis Healthcare
|
ICICI Securities Limited
|
664.55
|
331.00
|
301.50
(120.41%)
|
Target met |
Accumulate
|
|
|
Fortis Healthcare’s (FHL) Q2FY23 performance was broadly in line with our estimates. Revenues grew 9.9% YoY to Rs16.0bn (I-Sec: Rs16.2bn) with hospital segment growing 18.1% YoY.
|
|
14 Nov 2022
|
Fortis Healthcare
|
Prabhudas Lilladhar
|
664.55
|
360.00
|
301.50
(120.41%)
|
Target met |
Buy
|
|
|
|
|
23 Sep 2022
|
Fortis Healthcare
|
ICICI Securities Limited
|
664.55
|
299.00
|
265.55
(150.25%)
|
Target met |
Accumulate
|
|
|
The Supreme Court of India (SC) has announced its judgement in the Daiichi Sankyo-Fortis-IHH case.
|
|
10 Aug 2022
|
Fortis Healthcare
|
ICICI Securities Limited
|
664.55
|
299.00
|
269.15
(146.91%)
|
Target met |
Accumulate
|
|
|
Fortis Healthcare’s (FHL) Q1FY23 performance was broadly in line with our estimates. Revenues grew 5.5% YoY to Rs14.9bn (I-Sec: Rs14.5bn) with hospital segment growing 18.5% YoY.
|
|
09 Aug 2022
|
Fortis Healthcare
|
Prabhudas Lilladhar
|
664.55
|
330.00
|
267.30
(148.62%)
|
Target met |
Buy
|
|
|
|
|
27 May 2022
|
Fortis Healthcare
|
Prabhudas Lilladhar
|
664.55
|
330.00
|
244.70
(171.58%)
|
|
Buy
|
|
|
|